Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Lumbar spinal stenosis

Essential points for quick revision.

Saved on this device
!
New cauda equina dysfunction or rapidly progressive weakness

Chronic degenerative stenosis usually evolves gradually, but new bladder, bowel, sexual or saddle dysfunction, rapidly progressive bilateral weakness or loss of walking may represent acute cauda equina compromise or another superimposed lesion.

Action: Use the immediate local cauda equina or emergency spinal pathway, obtain urgent specialist imaging and do not attribute acute deterioration to the person’s baseline claudication.

Synopsis

Recognise posture-dependent neurogenic claudication, distinguish it from vascular and hip disease, investigate concordantly, and select conservative or decompressive care without using epidural injections for central-stenosis claudication.

  • Lumbar spinal stenosis is anatomical narrowing; the clinical syndrome is usually neurogenic claudication—leg discomfort, heaviness, paraesthesia or weakness provoked by standing or walking and relieved by sitting or lumbar flexion.
  • Posture matters more than a fixed distance: uphill walking, cycling or leaning on a trolley may be easier than standing upright. Vascular claudication is more tightly related to exertional demand and requires pulse and vascular-risk assessment.
  • MRI severity correlates imperfectly with disability. Diagnose from a compatible syndrome plus concordant anatomy, while excluding hip disease, peripheral neuropathy, vascular insufficiency and cervical or thoracic myelopathy.

Key red flags

New pelvic-organ or saddle symptoms with radiating low-back pain require immediate cauda equina assessment, even in someone with longstanding stenosis.

Rapidly progressive bilateral weakness, falls from neurological loss or inability to walk demands urgent spinal evaluation.

Pain at rest with an acutely cold, pale or pulseless limb is vascular emergency disease, not neurogenic claudication.

Fever, immune compromise, recent infection or spinal intervention raises epidural infection; cancer history, weight loss or unremitting night pain raises malignancy.

A sensory level, spasticity, extensor plantar responses or upper-limb signs imply cord disease above the lumbar roots.

Severe hip pain with inability to bear weight, trauma or systemic illness needs an alternative musculoskeletal or medical pathway.

Cauda equina deterioration

New urinary, bowel, sexual or saddle dysfunction with radiating low-back pain is an immediate-referral trigger and must not be dismissed as progression of chronic walking limitation.

Myelopathy masquerade

Spastic gait, brisk reflexes, extensor plantars, a sensory level or hand dysfunction cannot be explained by lumbar canal narrowing; assess cervical and thoracic cord disease urgently when progressive.

Investigation priorities

01
Functional and neurological examinationFirst step

Reproduce walking limitation, document gait and root function, and screen for hip, vascular and cord alternatives.

Management branches

Neurogenic claudication pathwayPersistent posture-dependent walking limitation

An adult has typical neurogenic claudication without acute cauda equina dysfunction.

  1. Explain the condition, support activity and offer tailored exercise or rehabilitation aimed at walking tolerance, strength and confidence while modifying aggravating load.
  2. Do not offer an epidural injection for neurogenic claudication caused by central spinal canal stenosis; review analgesic risk and investigate vascular, hip or neurological alternatives when indicated.

Key medicines

Oral NSAIDIf appropriate, use the lowest effective dose for the shortest period in line with the exact product and the patient’s risk profile.Assess gastrointestinal, renal, liver and cardiovascular toxicity, interacting medicines and frailty. Consider gastroprotection and monitoring; stop or review promptly if harms outweigh benefit.
Opioid or gabapentinoid escalationDo not use as an automatic long-term response to walking-limited stenosis; where the presentation is sciatica, follow NICE class-specific recommendations.Review existing therapy and arrange gradual supported withdrawal where appropriate rather than abrupt cessation. Separate neuropathic conditions with licensed indications from sciatica-specific NICE advice.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 13 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom